Prescription Option: Low-Dose Erythromycin (Prokinetic Use) Erythromycin at sub-antibiotic doses (50-125 mg before meals) acts as a motilin receptor agonist and is used off-label for gastroparesis
Internationally, tirzepatide has secured approvals for multiple indications in key markets, including China, where it has entered the national reimbursement systemsignificantly improving patient access
Many people prefer a natural approach, and many do best with a combined strategy
It is important to note that insulin does not increase glucose uptake into neurons via the insulin-sensitive glucose uptake transporter 4 (GLUT4)
Notably, these medications are not recommended for patients with severe gastroparesis or other significant gastrointestinal disorders, as stated in their FDA labeling
Evidencing changes indicate the possibility of prebiotics having neuroprotective, stress-buffering effects through the modulation of the MGBA by restoring microbial homeostasis, changing neuroendocrine responses, or affecting gene expression in stress-related brain regions (Burokas et al., 2017)